Acumen Pharmaceuticals, Inc. - 10-Q Filing
Acumen Pharmaceuticals reports third quarter 2026 financial results for period ended September 30, 2026.
Tickers: $ABOS
Read the full article at SEC EDGAR
Part of the story Phathom Pharmaceuticals, Inc. - 8-K Filing (3 articles)